D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
Enterprise Financial Services Corp
EFSC
$2.44B
| $579K | ﹤0.01% |
+12,794
| New | +$573K |
|
3852
Luxfer Holdings
LXFR
$456M
| $579K | ﹤0.01% |
29,483
-7,421
| -20% | -$153K |
|
3853
CALL
Credicorp
BAP
$30.9B
| $577K | ﹤0.01% |
5,200
| – | – |
|
|
ICVX
3854
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $577K | ﹤0.01% |
+19,507
| New | +$661K |
|
3855
ANI Pharmaceuticals
ANIP
$1.84B
| $575K | ﹤0.01% |
17,515
-7,399
| -30% | -$230K |
|
3856
Deutsche Bank
DB
$67.6B
| $571K | ﹤0.01% |
44,926
| – | – |
|
3857
PUT
D.R. Horton
DHI
$42.3B
| $571K | ﹤0.01% |
6,800
-11,500
| -63% | -$1.06M |
|
3858
MasterCraft Boat Holdings
MCFT
$607M
| $570K | ﹤0.01% |
+22,712
| New | +$582K |
|
|
LFC
3859
DELISTED
China Life Insurance Company Ltd.
LFC
| $570K | ﹤0.01% |
347,000
-2,673,000
| -89% | -$22.9M |
|
3860
ALX Oncology
ALXO
$268M
| $569K | ﹤0.01% |
7,710
-38,109
| -83% | -$2.54M |
|
3861
CarParts.com
PRTS
$42.4M
| $569K | ﹤0.01% |
3,645
-132
| -3% | -$22.9K |
|
|
EB
3862
CALL
DELISTED
Eventbrite
EB
| $567K | ﹤0.01% |
30,000
-120,000
| -80% | -$2.11M |
|
3863
Exponent
EXPO
$3.15B
| $567K | ﹤0.01% |
5,010
-26,487
| -84% | -$2.86M |
|
3864
Pool Corp
POOL
$7B
| $563K | ﹤0.01% |
1,297
-34,443
| -96% | -$16.3M |
|
3865
HBT Financial
HBT
$1.31B
| $562K | ﹤0.01% |
36,174
+77
| +0.2% | +$1.25K |
|
3866
GSK
GSK
$108B
| $561K | ﹤0.01% |
11,751
+3,971
| +51% | +$199K |
|
3867
CALL
Franco-Nevada
FNV
$40.6B
| $559K | ﹤0.01% |
4,300
-900
| -17% | -$132K |
|
|
OSG
3868
Octave Specialty Group
OSG
$261M
| $558K | ﹤0.01% |
38,990
-30,008
| -43% | -$428K |
|
3869
AYTU BioPharma
AYTU
$22.9M
| $557K | ﹤0.01% |
9,668
+4,872
| +102% | +$366K |
|
3870
Heritage Financial
HFWA
$1.22B
| $554K | ﹤0.01% |
21,726
+9,480
| +77% | +$230K |
|
3871
PUT
Gaotu Techedu
GOTU
$384M
| $553K | ﹤0.01% |
180,000
+40,000
| +29% | +$202K |
|
3872
Northwest Bancshares
NWBI
$2.33B
| $551K | ﹤0.01% |
41,489
-85,659
| -67% | -$1.13M |
|
3873
Stoneridge
SRI
$208M
| $550K | ﹤0.01% |
26,996
+4,617
| +21% | +$114K |
|
|
SPPI
3874
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $550K | ﹤0.01% |
252,625
-320,773
| -56% | -$876K |
|
3875
CALL
NXP Semiconductors
NXPI
$65.4B
| $548K | ﹤0.01% |
+2,800
| New | +$581K |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.